(Q37798183)

23 August 2017

Encapsulating peritoneal sclerosis: a single-center experience and review of the literature (English)

1 reference

23 August 2017

Konstantina Trigka

1

1 reference

23 August 2017

Periklis Dousdampanis

2

1 reference

23 August 2017

Maggie Chu

3

1 reference

23 August 2017

Saimah Khan

4

1 reference

23 August 2017

Mufazzal Ahmad

5

1 reference

23 August 2017

Joanne M Bargman

6

1 reference

23 August 2017

Dimitrios G Oreopoulos

7

1 reference

23 August 2017

6 October 2010

1 reference

International Urology and Nephrology

23 August 2017

1 reference

23 August 2017

43

1 reference

23 August 2017

2

1 reference

23 August 2017

519-526

1 reference

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis

23 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Encapsulating peritoneal sclerosis in the new millennium: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Sclerosing peritonitis: the experience in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Pleural fibrosis after practolol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Biological markers in the peritoneal dialysate effluent: are they useful

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Tamoxifen for retroperitoneal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Effects of tamoxifen on normal human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9848-Y

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study

21 January 2018

1 reference

12 December 2020

Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.

1 reference

12 December 2020

New animal models for encapsulating peritoneal sclerosis--role of acidic solution.

1 reference

12 December 2020

Hypothesis: gender and encapsulating peritoneal sclerosis

1 reference

12 December 2020

Epidemiology of encapsulating peritoneal sclerosis in Japan.

1 reference

12 December 2020

Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.

1 reference

12 December 2020

Patients on chronic peritoneal dialysis for ten years or more in North America

1 reference

12 December 2020

Successful surgical management of encapsulating peritoneal sclerosis.

1 reference

12 December 2020

Predictors of outcome following bacterial peritonitis in peritoneal dialysis

1 reference

12 December 2020

Successful treatment of retroperitoneal fibrosis with tamoxifen in a child.

1 reference

12 December 2020

Case-control study to determine the cause of sclerosing peritoneal disease.

1 reference

12 December 2020

Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions

1 reference

12 December 2020

Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species.

1 reference

12 December 2020

Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis

1 reference

12 December 2020

Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation

1 reference

12 December 2020

Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen.

1 reference

12 December 2020

[Our experience in the treatment of retroperitoneal fibrosis]

1 reference

12 December 2020

Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.

1 reference

12 December 2020

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads

1 reference

12 December 2020

10.1007/S11255-010-9848-Y

Identifiers

DOI

1 reference

23 August 2017

1 reference